Studiul nivelului de infectare cu virusul hepatic C a pacienţilor hemodializaţi şi a personalului din secţia de hemodializă

Isac Marina; Spânu Constantin; Guriev Vladimir; Sajin Octavian; Iarovoi Petru; Spînu Igor; Mastak Dumitru

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

548

Ultima descărcare din IBN:
2020-09-23 21:08

SM ISO690:2012

ISAC, Marina, SPÂNU, Constantin, GURIEV, Vladimir, SAJIN, Octavian, IAROVOI, Petru, SPÎNU, Igor, MASTAK, Dumitru. Studiul nivelului de infectare cu virusul hepatic C a pacienţilor hemodializaţi şi a personalului din secţia de hemodializă. In: Sănătate Publică, Economie şi Management în Medicină , 2012, nr. 5(44), pp. 72-75. ISSN 1729-8687.

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Sănătate Publică, Economie şi Management în Medicină

Numărul 5(44) / 2012 / ISSN 1729-8687 /ISSNe 2587-3873

Studiul nivelului de infectare cu virusul hepatic C a pacienţilor hemodializaţi şi a personalului din secţia de hemodializă

Study the level of infection with hepatitis C virus in patients on hemodialysis and personal of hemodialysis department

Уровень инфицированности вирусом гепатита С у пациентов на гемодиализе и сотрудников отдела гемодиализа.

Pag. 72-75

Isac Marina¹, Spânu Constantin¹, Guriev Vladimir¹, Sajin Octavian¹, Iarovoi Petru¹, Spînu Igor¹, Mastak Dumitru²

¹ Centrul Naţional de Sanătate Publică,
² IMSP Institutul de Medicină Urgentă

Disponibil în IBN: 16 mai 2020

Descarcă PDF

Rezumat

Viral hepatitis C is a significant problem for patients on hemodialysis. According to the literature in Romania, in 174 studied patients 39,2% were positive for anti-HCV antibodies, in Macedonia – 24.2%, in Turkey – 20.2%, respectively. The study of the level of infection with viral hepatitis C in hemodialysed patients from Republic of Moldova have shown that 40,7% were positive to anti-HCV antibodies and in 79.2% of those positive patients were detected IgM anti-HCV. Thus, hemodialysis patients represent one of the groups at high risk of infection with viral hepatitis C.

Вирусный гепатит С представляет значительную проблему для пациентов, находящихся на гемодиализе. По данным литературы, в Румынии из 174 обследованных пациентов у 39,2% выявлены anti-HCV, в Македонии – у 24,2%, в Турции – у 20,2%. Результаты исследований показали, что у 40,7% пациентов секции гемодиализа выявлены anti-HCV и у 79,2% позитивных на anti-HCV обнаружены IgM anti-HCV. Так, пациенты секции гемодиализа представляют одну из групп высокого риска инфицирования вирусным гепатитом С.

Cuvinte-cheie
viral hepatitis C, hemodialysed patients, anti/ HCV antibodies,

вирусный гепатит С, пациент, гемодиализ, антитела anti-HCV

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-103810</cfResPublId>
<cfResPublDate>2012-09-01</cfResPublDate>
<cfVol>44</cfVol>
<cfIssue>5</cfIssue>
<cfStartPage>72</cfStartPage>
<cfISSN>1729-8687</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/103810</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Studiul nivelului de infectare cu virusul hepatic C a pacienţilor hemodializaţi şi a personalului din secţia de hemodializă</cfTitle>
<cfKeyw cfLangCode='RO' cfTrans='o'>viral hepatitis C; hemodialysed
patients; anti/ HCV
antibodies; вирусный гепатит С; пациент; гемодиализ; антитела anti-HCV</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>Viral hepatitis C is a significant problem for patients on hemodialysis. According to the literature in Romania, in 174 studied patients 39,2% were positive for anti-HCV antibodies, in Macedonia &ndash; 24.2%, in Turkey &ndash; 20.2%, respectively. The study of the level of infection with viral hepatitis C in hemodialysed patients from Republic of Moldova have shown that 40,7% were positive to anti-HCV antibodies and in 79.2% of those positive patients were detected IgM anti-HCV. Thus, hemodialysis patients represent one of the groups at high risk of infection with viral hepatitis C.</p></cfAbstr>
<cfAbstr cfLangCode='RU' cfTrans='o'><p>Вирусный гепатит С представляет значительную проблему для пациентов, находящихся на гемодиализе. По данным литературы, в Румынии из 174 обследованных пациентов у 39,2% выявлены anti-HCV, в Македонии &ndash; у 24,2%, в Турции &ndash; у 20,2%. Результаты исследований показали, что у 40,7% пациентов секции гемодиализа выявлены anti-HCV и у 79,2% позитивных на anti-HCV обнаружены IgM anti-HCV. Так, пациенты секции гемодиализа представляют одну из групп высокого риска инфицирования вирусным гепатитом С.</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-17719</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11974</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-32620</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-26482</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11732</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-13425</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-20624</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-17719</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-17719-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Isac</cfFamilyNames>
<cfFirstNames>Marina</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11974</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11974-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Spânu</cfFamilyNames>
<cfFirstNames>Constantin</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-32620</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-32620-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Guriev</cfFamilyNames>
<cfFirstNames>Vladimir</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-26482</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-26482-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Sajin</cfFamilyNames>
<cfFirstNames>Octavian</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11732</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11732-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Iarovoi</cfFamilyNames>
<cfFirstNames>Petru</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-13425</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13425-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Spînu</cfFamilyNames>
<cfFirstNames>Igor</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-20624</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-20624-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Мастак</cfFamilyNames>
<cfFirstNames>Дмитрий</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>